Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Delayed Early Genes Prevent Runaway Cell Division

By Biotechdaily staff writers
Posted on 05 Mar 2007
Cancer researchers have identified a cluster of genes in normal cells that prevent the type of runaway cell division that characterizes cancer cells.
When normal cells respond to the correct outside stimulus, such as binding of epidermal growth factor, to divide, a group of genes termed "immediate early genes” begin to function. More...
Immediate early genes (IEGs) are activated transiently and rapidly in response to a wide variety of cellular stimuli. They represent a standing response mechanism that is activated at the transcription level in the first round of response to stimuli, before any new proteins are synthesized. Thus, IEGs are distinct from "late response” genes, which can only be activated later following the synthesis of early response gene products.
In the current study, investigators at the Weizmann Institute of Science (Rehovot, Israel) identified a distinct subset of IEGs that they call "delayed” early genes. The task of these genes is to suppress IEG activity so that cell division stops and does not spin out of control.
Their study, published in the February 25, 2007, online edition of Nature Genetics, revealed that after being triggered by the proper stimulus, a first wave of IEGs initiated cell division and was active for from 20 to 40 minutes. After that, four more waves of genetic activity, ranging from 40 to 240 minutes after the signal, were comprised primarily of gene activity tied to the process of halting cell division. Overall, the investigators identified 50 genes that interfered with the activities of the first wave of genes. This inhibitory system functioned by producing proteins that directly attached to the cell-division genes, hindering their activity.

As might be anticipated, analysis of the activity of the delayed early genes in cancerous tissues showed that they did not function or functioned only poorly. This misbehavior was directly linked to the aggressiveness of the cancer and the likelihood of the patient to recover.


Related Links:
Weizmann Institute of Science

Gold Member
Automated MALDI-TOF MS System
EXS 3000
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Immunology

view channel
Image: The simple blood marker can predict which lymphoma patients will benefit most from CAR T-cell therapy (Photo courtesy of Shutterstock)

Routine Blood Test Can Predict Who Benefits Most from CAR T-Cell Therapy

CAR T-cell therapy has transformed treatment for patients with relapsed or treatment-resistant non-Hodgkin lymphoma, but many patients eventually relapse despite an initial response. Clinicians currently... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.